Deciphering the lithium transcriptome: Microarray profiling of lithium-modulated gene expression in human neuronal cells

Neuroscience

Volumn 151, Issue 4, 2008, Pages 1184-1197

  Seelan, R S ^a,d   Khalyfa, A ^b   Lakshmanan, J ^a,d   Casanova, M F ^a   Parthasarathy, R N ^a,c,d  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF LOUISVILLE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

autophagy; bipolar disorder; inositol; lithium response element; PRDX2; TRB3

Indexed keywords

CELL PROTEIN; LITHIUM; MESSENGER RNA; PEROXIREDOXIN; PEROXIREDOXIN 2; PHOSPHATIDYL INOSITOL 4 PHOSPHATE 5 KINASE TYPE 2 ALPHA; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL; PROTEIN SNX 14; PROTEIN TRB 3; PROTEIN WIPI 49; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; NERVE CELL; PRIORITY JOURNAL; RODENT; UPREGULATION;

ANTIPSYCHOTIC AGENTS; CELL LINE, TUMOR; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LITHIUM; NEUROBLASTOMA;

EID: 39149096239     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2007.10.045     Document Type: Article

References (80)

1. Benjamini Y., and Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B 57 (1995) 289-300
2. Berridge M.J., Downes C.P., and Hanley M.R. Neural and developmental actions of lithium: a unifying hypothesis. Cell 59 (1989) 411-419
3. Berry G.T., Buccafusca R., Greer J.J., and Eccleston E. Phosphoinositide deficiency due to inositol depletion is not a mechanism of lithium action in brain. Mol Genet Metab 82 (2004) 87-92
4. Birnbaum S.G., Yuan P.X., Wang M., Vijayraghavan S., Bloom A.K., Davis D.J., Gobeske K.T., Sweatt J.D., Manji H.K., and Arnsten A.F. Protein kinase C overactivity impairs prefrontal cortical regulation of working memory. Science 306 (2004) 882-884
5. Bosetti F., Seemann R., Bell J.M., Zahorchak R., Friedman E., Rapoport S.I., and Manickam P. Analysis of gene expression with cDNA microarrays in rat brain after 7 and 42 days of oral lithium administration. Brain Res Bull 57 (2002) 205-209
6. Brandish P.E., Su M., Holder D.J., Hodor P., Szumiloski J., Kleinhanz R.R., Forbes J.E., McWhorter M.E., Duenwald S.J., Parrish M.L., Na S., Liu Y., Phillips R.L., Renger J.J., Sankaranarayanan S., Simon A.J., and Scolnick E.M. Regulation of gene expression by lithium and depletion of inositol in slices of adult rat cortex. Neuron 45 (2005) 861-872
7. Broulik P.D., Stepan J.J., Soucek K., and Pacovsky V. Alterations in human serum alkaline phosphatase and its bone isoenzyme by chronic administration of lithium. Clin Chim Acta 140 (1984) 151-155
8. Cade J.F. Lithium salts in the treatment of psychotic excitement. Med J Aust 2 (1949) 349-352
9. Carroll P., Renoncourt Y., Gayet O., De Bovis B., and Alonso S. Sorting nexin-14, a gene expressed in motoneurons trapped by an in vitro preselection method. Dev Dyn 221 (2001) 431-442
10. Chen C.L., Lin C.F., Chiang C.W., Jan M.S., and Lin Y.S. Lithium inhibits ceramide- and etoposide-induced protein phosphatase 2A methylation, Bcl-2 dephosphorylation, caspase-2 activation, and apoptosis. Mol Pharmacol 70 (2006) 510-517
11. Chen G., and Manji H.K. The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers. Curr Opin Psychiatry 19 (2006) 313-323
12. Chen R.W., and Chuang D.M. Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity. J Biol Chem 274 (1999) 6039-6042
13. Colton C.A., Mott R.T., Sharpe H., Xu Q., Van Nostrand W.E., and Vitek M.P. Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J Neuroinflammation 3 (2006) 27
14. Einat H., and Manji H.K. Cellular plasticity cascades: genes-to-behavior pathways in animal models of bipolar disorder. Biol Psychiatry 59 (2006) 1160-1171
15. Gray N.A., Du J., Falke C.S., Yuan P., and Manji H.K. Lithium regulates total and synaptic expression of the AMPA glutamate receptor GluR2 in vitro and in vivo. Ann N Y Acad Sci 1003 (2003) 402-404
16. Gulesserian T., Engidawork E., Fountoulakis M., and Lubec G. Antioxidant proteins in fetal brain: superoxide dismutase-1 (SOD-1) is not overexpressed in fetal Down syndrome. J Neural Transm Suppl 61 (2001) 71-84
17. Gurvich N., and Klein P.S. Lithium and valproic acid: parallels and contrasts in diverse signaling contexts. Pharmacol Ther 96 (2002) 45-66
18. Hahn C.G., and Friedman E. Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder. Bipolar Disord 1 (1999) 81-86
19. Hahn C.G., Umapathy, Wang H.Y., Koneru R., Levinson D.F., and Friedman E. Lithium and valproic acid treatments reduce PKC activation and receptor-G protein coupling in platelets of bipolar manic patients. J Psychiatr Res 39 (2005) 355-363
20. Hallcher L.M., and Sherman W.R. The effects of lithium ion and other agents on the activity of myo-inositol 1-phosphatase from bovine brain. J Biol Chem 255 (1980) 10896-10901
21. Hammond W.A. Insanity. A treatise on the diseases of the nervous system (1873), Appleton D & Co, New York 381
22. Harwood A.J. Lithium and bipolar mood disorder: the inositol-depletion hypothesis revisited. Mol Psychiatry 10 (2005) 117-126
23. Huang R., Murry D.J., Kolwankar D., Hall S.D., and Foster D.R. Vincristine transcriptional regulation of efflux drug transporters in carcinoma cell lines. Biochem Pharmacol 71 (2006) 1695-1704
24. Ichimiya S., Davis J.G., O'Rourke D.M., Katsumata M., and Greene M.I. Murine thioredoxin peroxidase delays neuronal apoptosis and is expressed in areas of the brain most susceptible to hypoxic ischemic injury. DNA Cell Biol 16 (1997) 311-321
25. 2+. J Biol Chem 262 (1987) 15946-15952
26. Jamra R.A., Klein K., Villela A.W., Becker T., Schulze T.G., Schmael C., Deschner M., Klopp N., Illig T., Propping P., Cichon S., Rietschel M., Nothen M.M., and Schumacher J. Association study between genetic variants at the PIP5K2A gene locus and schizophrenia and bipolar affective disorder. Am J Med Genet B Neuropsychiatr Genet 141 (2006) 663-665
27. Jope R.S. Anti-bipolar therapy: mechanism of action of lithium. Mol Psychiatry 4 (1999) 117-128
28. Kaga S., Zhan L., Altaf E., and Maulik N. Glycogen synthase kinase-3β/β-catenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium. J Mol Cell Cardiol 40 (2006) 138-147
29. Kim H., Lee T.H., Park E.S., Suh J.M., Park S.J., Chung H.K., Kwon O.Y., Kim Y.K., Ro H.K., and Shong M. Role of peroxiredoxins in regulating intracellular hydrogen peroxide and hydrogen peroxide-induced apoptosis in thyroid cells. J Biol Chem 275 (2000) 18266-18270
30. Kim S.H., Fountoulakis M., Cairns N., and Lubec G. Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer's disease and Down syndrome. J Neural Transm Suppl 61 (2001) 223-235
31. Kiss-Toth E., Bagstaff S.M., Sung H.Y., Jozsa V., Dempsey C., Caunt J.C., Oxley K.M., Wyllie D.H., Polgar T., Harte M., O'Neill L.A., Qwarnstrom E.E., and Dower S.K. Human tribbles, a protein family controlling mitogen-activated protein kinase cascades. J Biol Chem 279 (2004) 42703-42708
32. Kobayashi K., Era T., Takebe A., Jakt L.M., and Nishikawa S. ARID3B induces malignant transformation of mouse embryonic fibroblasts and is strongly associated with malignant neuroblastoma. Cancer Res 66 (2006) 8331-8336
33. Krapfenbauer K., Engidawork E., Cairns N., Fountoulakis M., and Lubec G. Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders. Brain Res 967 (2003) 152-160
34. Lal A., Kawai T., Yang X., Mazan-Mamczarz K., and Gorospe M. Antiapoptotic function of RNA-binding protein HuR effected through prothymosin α. EMBO J 24 (2005) 1852-1862
35. Lenox R.H., and Wang L. Molecular basis of lithium action: integration of lithium-responsive signaling and gene expression networks. Mol Psychiatry 8 (2003) 135-144
36. Li C., Zheng Y., Qin W., Tao R., Pan Y., Xu Y., Li X., Gu N., Feng G., and He L. A family-based association study of kinesin heavy chain member 2 gene (KIF2) and schizophrenia. Neurosci Lett 407 (2006) 151-155
37. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25 (2001) 402-408
38. Malicet C., Giroux V., Vasseur S., Dagorn J.C., Neira J.L., and Iovanna J.L. Regulation of apoptosis by the p8/prothymosin alpha complex. Proc Natl Acad Sci U S A 103 (2006) 2671-2676
39. Manji H.K., Moore G.J., and Chen G. Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilizers. Br J Psychiatry 178 Suppl 41 (2001) s107-s119
40. Mayumi-Matsuda K., Kojima S., Suzuki H., and Sakata T. Identification of a novel kinase-like gene induced during neuronal cell death. Biochem Biophys Res Commun 258 (1999) 260-264
41. McGill J.K., and Beal M.F. PGC-1α, a new therapeutic target in Huntington's disease?. Cell 127 (2006) 465-468
42. McQuillin A., Rizig M., and Gurling H.M.D. A microarray gene expression study of the molecular pharmacology of lithium carbonate on mouse brain mRNA to understand the neurobiology of mood stabilization and treatment of bipolar affective disorder. Pharmacogenet Genomics 17 (2007) 605-617
43. Messiha F.S. Lithium and the neonate: developmental and metabolic aspects. Alcohol 3 (1986) 107-112
44. Messiha F.S., Sproat H.F., and Striegler R.L. Chlorpromazine and lithium interaction: a biochemical and histological study. Brain Res Bull 11 (1983) 249-253
45. Morfini G., Quiroga S., Rosa A., Kosik K., and Caceres A. Suppression of KIF2 in PC12 cells alters the distribution of a growth cone nonsynaptic membrane receptor and inhibits neurite extension. J Cell Biol 138 (1997) 657-669
46. Morowitz M., Shusterman S., Mosse Y., Hii G., Winter C.L., Khazi D., Wang Q., King R., and Maris J.M. Detection of single-copy chromosome 17q gain in human neuroblastomas using real-time quantitative polymerase chain reaction. Mod Pathol 16 (2003) 1248-1256
47. Ozaki N., and Chuang D.M. Lithium increases transcription factor binding to AP-1 and cyclic AMP-responsive element in cultured neurons and rat brain. J Neurochem 69 (1997) 2336-2344
48. Parthasarathy L., Seelan R.S., Wilson M.A., Vadnal R.E., and Parthasarathy R.N. Regional changes in rat brain inositol monophosphatase 1 (IMPase 1) activity with chronic lithium treatment. Prog Neuropsychopharmacol Biol Psychiatry 27 (2003) 55-60
49. Pfuhl T., Durr M., Spurk A., Schwalbert B., Nord R., Mysliwietz J., Kremmer E., and Grasser F.A. Biochemical characterisation of the proteins encoded by the DiGeorge critical region 6 (DGCR6) genes. Hum Genet 117 (2005) 70-80
50. Proikas-Cezanne T., Waddell S., Gaugel A., Frickey T., Lupas A., and Nordheim A. WIPI-1α (WIPI49), a member of the novel 7-bladed WIPI protein family, is aberrantly expressed in human cancer and is linked to starvation-induced autophagy. Oncogene 23 (2004) 9314-9325
51. Rampazzo A., Beffagna G., Nava A., Occhi G., Bauce B., Noiato M., Basso C., Frigo G., Thiene G., Towbin J., and Danieli G.A. Arrhythmogenic right ventricular cardiomyopathy type 1 (ARVD1): confirmation of locus assignment and mutation screening of four candidate genes. Eur J Hum Genet 11 (2003) 69-76
52. Rodriguez de la Concepcion M.L., Yubero P., Iglesias R., Giralt M., and Villarroya F. Lithium inhibits brown adipocyte differentiation. FEBS Lett 579 (2005) 1670-1674
53. Rojek A., Nielsen J., Brooks H.L., Gong H., Kim Y.H., Kwon T.H., Frokiaer J., and Nielsen S. Altered expression of selected genes in kidney of rats with lithium-induced NDI. Am J Physiol Renal Physiol 288 (2005) F1276-F1289
54. Ryves W.J., and Harwood A.J. Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. Biochem Biophys Res Commun 280 (2001) 720-725
55. Sanchez-Font M.F., Sebastia J., Sanfeliu C., Cristofol R., Marfany G., and Gonzalez-Duarte R. Peroxiredoxin 2 (PRDX2), an antioxidant enzyme, is under-expressed in Down syndrome fetal brains. Cell Mol Life Sci 60 (2003) 1513-1523
56. Sarafian T.A., Verity M.A., Vinters H.V., Shih V.C.Y., Shi L., Ji X.D., Dong L., and Shau H. Differential expression of peroxiredoxin subtypes in human brain cell types. J Neurosci 56 (1999) 206-212
57. Sarkar S., and Rubinsztein D.C. Inositol and IP3 levels regulate autophagy: biology and therapeutic speculations. Autophagy 2 (2006) 132-134
58. Schwab S.G., Knapp M., Sklar P., Eckstein G.N., Sewekow C., Borrmann-Hassenbach M., Albus M., Becker T., Hallmayer J.F., Lerer B., Maier W., and Wildenauer D.B. Evidence for association of DNA sequence variants in the phosphatidylinositol-4-phosphate 5-kinase II alpha gene (PIP5K2A) with schizophrenia. Mol Psychiatry 11 (2006) 837-846
59. Schwarzer R., Dames S., Tondera D., Klippel A., and Kaufmann J. TRB3 is a PI 3-kinase dependent indicator for nutrient starvation. Cell Signal 18 (2006) 899-909
60. Shamir A., Shaltiel G., Greenberg M.L., Belmaker R.H., and Agam G. The effect of lithium on expression of genes for inositol biosynthetic enzymes in mouse hippocampus; a comparison with a yeast model. Brain Res Mol Brain Res 115 (2003) 104-110
61. Sharma S.D., and Iqbal M. Lithium induced toxicity in rats: a hematological, biochemical and histopathological study. Biol Pharm Bull 28 (2005) 834-837
62. Shintani T., and Klionsky D.J. Autophagy in health and disease: A double-edged sword. Science 306 (2004) 990-995
63. Stopkova P., Saito T., Fann C.S., Papolos D.F., Vevera J., Paclt I., Zukov I., Stryjer R., Strous R.D., and Lachman H.M. Polymorphism screening of PIP5K2A: a candidate gene for chromosome 10p-linked psychiatric disorders. Am J Med Genet B Neuropsychiatr Genet 123 (2003) 50-58
64. Tao R., Yu Y., Zhang X., Guo Y., Shi J., Zhang X., Xie L., Liu S., Ju G., Xu Q., Shen Y., and Wei J. Cytosolic PLA2 genes possibly contribute to the etiology of schizophrenia. Am J Med Genet B Neuropsychiatr Genet 137 (2005) 56-58
65. Traina F., Favaro P.M.B., de Souza Medina S., da Silva Santos Duarte A., Winnischofer S.M.B., Costa F.F., and Saad S.T.O. ANKHD1, ankyrin repeat and KH domain containing 1, is overexpressed in acute leukemias and is associated with SHP2 in K562 cells. Biochim Biophys Acta 1762 (2006) 828-834
66. Wada A., Yokoo H., Yanagita T., and Kobayashi H. Lithium: potential therapeutics against acute brain injuries and chronic neurodegenerative diseases. J Pharmacol Sci 99 (2005) 307-321
67. Wang L., Liu X., and Lenox R.H. Transcriptional down-regulation of MARCKS gene expression in immortalized hippocampal cells by lithium. J Neurochem 79 (2001) 816-825
68. Watson S., and Young A.H. The place of lithium salts in psychiatric practice 50 years on. Curr Opin Psychiatry 14 (2001) 57-63
69. White P.S., Maris J.M., Beltinger C., Sulman E., Marshall H.N., Fujimori M., Kaufman B.A., Biegel J.A., Allen C., Hilliard C., Valentine M.B., Look A.T., Enomoto H., Sakiyama S., and Brodeur G.M. A region of consistent deletion in neuroblastoma. Proc Natl Acad Sci U S A 92 (1995) 5520-5524
70. Williams R.S., and Harwood A.J. Lithium therapy and signal transduction. Trends Pharmacol Sci 21 (2000) 61-64
71. Williams R.S.B., Cheng L., Mudge A.W., and Harwood A.J. A common mechanism of action for three mood-stabilizing drugs. Nature 417 (2002) 292-295
72. Wood J.R., Nelson-Degrave V.L., Jansen E., McAllister J.M., Mosselman S., and Strauss III J.F. Valproate-induced alterations in human theca cell gene expression: clues to the association between valproate use and metabolic side effects. Physiol Genomics 20 (2005) 233-243
73. Worby C.A., and Dixon J.E. Sorting out the cellular functions of sorting nexins. Nat Rev Mol Cell Biol 3 (2002) 919-931
74. Xia Z., Dickens M., Raingeaud J., Davis R.J., and Greenberg M.E. Opposing effects of ERK and JNK-p38 kinases on apoptosis. Science 270 (1995) 1326-1331
75. Xu Y., Seet L.F., Hanson B., and Hong W. The Phox homology (PX) domain, a new player in phosphoinositide signalling. Biochem J 360 (2001) 513-530
76. Youngs R.M., Chu M.S., Meloni E.G., Naydenov A., Carlezon Jr. W.A., and Konradi C. Lithium administration to preadolescent rats causes long-lasting increases in anxiety-like behavior and has molecular consequences. J Neurosci 26 (2006) 6031-6039
77. Yuan P.X., Chen G., Huang L.D., and Manji H.K. Lithium stimulates gene expression through the AP-1 transcription factor pathway. Brain Res Mol Brain Res 58 (1998) 225-230
78. Zhang P., Liu B., Kang S.W., Seo M.S., Rhee S.G., and Obeid L.M. Thioredoxin peroxidase is a novel inhibitor of apoptosis with a mechanism distinct from that of Bcl-2. J Biol Chem 272 (1997) 30615-30618
79. Zhang W.V., Jullig M., Connolly A.R., and Stott N.S. Early gene response in lithium chloride induced apoptosis. Apoptosis 10 (2005) 75-90
80. Zhen X., Torres C., and Friedman E. Lithium regulates protein tyrosine phosphatase activity in vitro and in vivo. Psychopharmacology 162 (2002) 379-384